IPOS News


  • 1 Feb 2024 2:10 PM | John Chagnon (Administrator)

    Psychiatrist

    Departments of Oncology and Psychiatry

    Cumming School of Medicine

    University of Calgary 

    We would like to take this opportunity to acknowledge the traditional territories of the people of the Treaty 7 region in Southern Alberta. The City of Calgary is also home to Métis Nation of Alberta (Districts 5 and 6).

    The Departments of Oncology and Psychiatry, Cumming School of Medicine, University of Calgary in conjunction with the Arnie Charbonneau Cancer Institute and Alberta Health Services, invite applications for a Contingent Term position within the discipline of Psychiatry, at the Professor level. 

    Qualifications include an MD and eligibility for registration with the College of Physicians and Surgeons of Alberta in Psychiatry and Certification or board eligibility in Psychiatry from the Royal College of Physicians and Surgeons of Canada.  Applicants must have 10 plus years of experience with special competency in a Psychiatry discipline, evidence of   continuous, externally funded (at the level of Tri-Council or equivalent peer reviewed National/International organization), an outstanding academic publication record as evidenced by continuous publication in high impact journals or leading in the field, demonstrated ability to lead research teams, outstanding teaching and graduate supervision record, and evidence of academic service leadership.

    The successful candidate will be an academic clinical psychiatrist with a track record in psychosocial oncology with special interests in palliative care, indigenous health and /or geriatric oncology.  In addition, the successful candidate will have a proven track record of leadership of diverse teams and will have an activity profile that will be in part in scope, servicing urban, rural and remote clinically applied academic investigation into unmet clinical needs.  

    The Department of Oncology and its eleven (11) clinical and academic divisions represent all major cancer disciplines.  Our key research streams align with the research foci of the Cumming School of Medicine, the Tom Baker Cancer Centre, the new Arthur J.E. Child Comprehensive Cancer Centre, the Arnie Charbonneau Cancer Institute, and with the cancer research priorities of Cancer Care Alberta.  Our clinical population and psychosocial research continuum within the Tom Baker Cancer Centre, the Holy Cross Centre and the new Arthur J.E. Child Comprehensive Cancer Centre support the Department of Oncology’s vision, mission, and values, which guide us through our research, academic and clinical service success as identified in the four strategic pillars that form the framework to achieve our success plans.  These include: i) Advancing our research foci, ii) Embracing our research leadership culture, iii) Building capacity, mentoring and supporting researchers, and iv) Fostering teamwork and collaboration.

    Scheduled to open to the public in 2024, the new 1.4 million square foot Arthur J.E. Child Comprehensive Cancer Centre will engage patients at the centre of a multidisciplinary health system, enabling access to comprehensive cancer care services in a world-class facility. In fact, the extensive scope and integration of cancer care services at the Arthur J.E. Child Comprehensive Cancer Centre will make it one of the most comprehensive cancer centres in the world. Integrated research across the spectrum will further optimize care with focus on prevention, early detection, precision medicine and psychosocial care.

    UCalgary is Canada’s entrepreneurial university, located in Canada’s most enterprising city. It is a top research university and one of the highest-ranked universities of its age. Founded in 1966, its 36,000 students experience an innovative learning environment, made rich by research, hands-on experiences and entrepreneurial thinking. It is Canada’s leader in the creation of start-ups. Start something today at the University of Calgary. For more information, visit ucalgary.ca.

    Calgary is one of the world’s cleanest cities and has been named one of the world’s most livable cities for years. Calgary is a city of leaders - in business, community, philanthropy and volunteerism. Calgarians benefit from a growing number of world-class dining and cultural events and enjoy more days of sunshine per year than any other major Canadian city. Calgary is less than an hour's drive from the majestic Rocky Mountains and boasts the most extensive urban pathway and bikeway network in North America. 

    The University of Calgary recognizes that candidates have varying career paths and that career interruptions can be part of an excellent academic record. Candidates are encouraged but not required to provide any relevant information about their experience and/or career interruptions to allow for a fair assessment of their application. Selection committees have been instructed to give careful consideration to, and be sensitive to the impact of career interruptions, when assessing the candidate’s research productivity.

    Interested individuals are encouraged to submit an application online via University of Calgary Careers webpage using the ‘Apply Now’ link.

    Please be aware that the application process allows for a maximum of four attachments. Your four application attachments should be organized to contain the following (you are encouraged to merge documents to reduce the number of attachments):

    • Cover letter
    • Curriculum vitae
    • Research interest statement (not to exceed 2 pages)
    • Leadership statement including equity, diversity and inclusion considerations (not to exceed 2 pages)
    • The names and contact information for three (3) referees. Reference letters will not be required unless the applicant is short-listed for a visit/interview. 

    View full posting and apply: https://careers.ucalgary.ca/jobs/13904164-psychiatrist-departments-of-oncology-and-psychiatry-cumming-school-of-medicine

    For more information please contact:

    Dr. Don Morris,

    Professor and Head

    Department of Oncology

    Email: [email protected]

    Application deadline: March 8, 2024

    To learn more about academic opportunities at the University of Calgary and all we have to offer, view our Academic Careers website (http://careers.ucalgary.ca/).  For more information about the Cumming School of Medicine visit Cumming School of Medicine | University of Calgary (ucalgary.ca).

    The University of Calgary strongly recommends all faculty and staff are fully vaccinated against COVID-19.

    The University of Calgary has launched an institution-wide Indigenous Strategy in line with the foundational goals of Eyes High, committing to creating a rich, vibrant, and culturally competent campus that welcomes and supports Indigenous Peoples, encourages Indigenous community partnerships, is inclusive of Indigenous perspectives in all that we do.

    As an equitable and inclusive employer, the University of Calgary recognizes that a diverse staff/faculty benefits and enriches the work, learning and research experiences of the entire campus and greater community. We are committed to removing barriers that have been historically encountered by some people in our society. We strive to recruit individuals who will further enhance our diversity and will support their academic and professional success while they are here. In particular, we encourage members of the designated groups (women, Indigenous peoples, persons with disabilities, members of visible/racialized minorities, and diverse sexual orientation and gender identities) to apply. To ensure a fair and equitable assessment, we offer accommodation at any stage during the recruitment process to applicants with disabilities. Questions regarding [diversity] EDI at UCalgary can be sent to the Office of Equity, Diversity and Inclusion ([email protected]) and requests for accommodations can be sent to Human Resources ([email protected]).

    All qualified candidates are encouraged to apply; however Canadians and permanent residents will be given priority. In this connection, at the time of your application, please answer the following question: Are you a Canadian citizen or a permanent resident of Canada? (Yes/No)

    Interested in advertising with IPOS? Click here to learn more.


  • 31 Jan 2024 10:33 AM | John Chagnon (Administrator)

    We are looking for volunteer members for our Special Interest Group: E-Health and AI (Artificial Intelligence)

    If you are a current member of IPOS and want to get involved, we have a great opportunity for you. Considering becoming a member of our Special Interest Group: E-Health and AI (Artificial Intelligence) Our goal is to have a group with members with broad experiences and perspectives. We also want members from all parts of the World!

    If you are a member of IPOS and have an interest in e-Health and/or Artificial Intelligence as it pertains to psychosocial oncology, this is the group for you!

    The co-chairs:

    • Carmen Loiselle – Canada
    • Claire Foster – United Kingdom
    • Tania Estape – Spain

    Please email [email protected] with your name, country and one sentence about why you are interested in volunteering with the Special Interest Group: E-Health and AI (Artificial Intelligence)

    Please submit by February 15, 2024.


  • 26 Jan 2024 3:06 PM | John Chagnon (Administrator)


    I am a psychologist at the psychosocial service of the Podоl Regional Oncology Center, Vinnytsia. I provide assistance in various departments: polyclinic, surgical, therapeutic. I also work with palliative patients.

    Since 2006, I have been one of the first pioneers in the development of psychosocial assistance services in Ukraine.

    I want to learn and collaborate with experts from around the world to improve psychiatric care for people with cancer, especially vulnerable populations, especially those who have been forcibly displaced by war and genocide.

    My goal is to develop and improve psychosocial oncology services in Ukraine.

    I restore the forgotten traditions of my people, I bake bread.

    Interested in being profiled?

    Please email the following to [email protected] with the subject line “IPOS member profile submission”:

    1. Name
    2. Employment position
    3. Employer/Institution
    4. Country
    5. Twitter handle (if available)
    6. Jpg photo of yourself
    7. 50-to-200-word description that notes details on your practice, involvement with IPOS and something “fun or interesting” about yourself.


  • 12 Jan 2024 9:22 AM | John Chagnon (Administrator)


    I am currently investigating depressive symptoms and cognitive impairments (memory problems, attention, mental agility...) associated with breast cancer. Specifically, I am studying possible biomarkers of both conditions and a home treatment that combines non-invasive brain stimulation techniques and cognitive training to improve these symptoms (NCT06053775). I became a member of IPOS because I believe that it will greatly contribute to enrich my professional practice, both clinical practice and research, by meeting professionals in this field and being up to date in therapeutic intervention with oncology patients. In addition, I believe that this membership will allow me to disseminate my work so that other professionals can get to know it. I have initiated this research project with the intention of learning more about one of the main sequelae of cancer, which often goes unnoticed by medical professionals and for which many patients do not receive treatment. I hope to be able to extend this knowledge to other populations, such as children, to improve the quality of life of these patients. I am confident that my background and enthusiasm will make this possible!

    Interested in being profiled?

    Please email the following to [email protected] with the subject line “IPOS member profile submission”:

    1. Name
    2. Employment position
    3. Employer/Institution
    4. Country
    5. Twitter handle (if available)
    6. Jpg photo of yourself
    7. 50-to-200-word description that notes details on your practice, involvement with IPOS and something “fun or interesting” about yourself.


  • 4 Jan 2024 12:52 PM | John Chagnon (Administrator)

    The Journal of Psychosocial Oncology Research and Practice is the official global journal of the International Psycho-Oncology Society (IPOS). This open access journal focuses on the growing body of research in the field of psychosocial oncology. The journal publishes articles reporting on clinical research examining psychosocial and behavioral interventions in oncology settings, research on the implementation of psychosocial and behavioral interventions in routine clinical practice and their impact on outcomes. This includes reports on pragmatic clinical trials, qualitative research, systematic reviews, survivorship research and care, psychosocial oncology research and practice in developing countries, innovative research methods and research into global and regional health disparities as they relate to psychosocial oncology care and services.

    First Name

    Last Name

    Country

    Khaled

    Al Omari

    Oman

    Chioma

    Asuzu

    Nigeria

    Alcon

    Barnett

    Jamaica

    Svetlana

    Baziliansky

    Israel

    Genevieve

    Breau

    Canada

    Rosario

    Costas-Muñiz

    USA

    Susanne

    Dalton

    Denmark

    Lauren

    Daniel

    USA

    Haryana

    Dhillon

    Australia

    Tania

    Estape

    Spain

    Claire

    Han

    USA

    Saki

    Harashima

    Japan

    Jochen

    Kaiser

    Germany

    Cramer

    Kallem

    USA

    Juliet

    Kroll

    USA

    Ken

    Kurisu

    Japan

    Wendy Wing Tak

    Lam

    Hong Kong, China

    Gerald

    Matua

    Oman

    Anja

    Mehnert-Theurkauf

    Germany

    Hitoshi

    Okamura

    Japan

    Masako

    Okamura

    Japan

    Ying

    Pang

    China

    Sarah

    Reed

    USA

    Lauren

    Rudy

    Canada

    Kelly

    Shaffer

    USA

    Mariana Alejandra

    Sierra- Murguía

    Mexico

    Ellen

    Sweeney

    Canada

    Miyako

    Takahashi

    Japan

    Rachel

    Taylor

    UK

    Kathleen

    Van Dyk

    USA

    Vicki

    White

    Australia

    Lori

    Wiener

    USA

    jeanette

    Winterling

    Sweden

    Nienke

    Zomerdijk

    Australia

    Find out more by going to https://journals.lww.com/jporp/pages/default.aspx


  • 21 Dec 2023 11:35 AM | John Chagnon (Administrator)
    Florina Pasca (Pop), PhD, clinical psychologist at the Oncological Institute Prof. dr.I. Chiricuta with more than 10 years of experience in Psycho-Oncology. I work with adult patients with various malignant pathologies. During the 10 years of activity, I participated in various conferences in the field of psychology, psychotherapy and psycho-oncology, but was also involved in research projects, including those aimed at online psycho-education for cancer patients and their families. I believe in continuous professional training, and her personal interests include quality of life, etiopathogenetic mechanisms involved in health and mental illness, multidisciplinarity in the care of cancer treatment and effective psycho-oncological interventions in emotional self-regulation of cancer patients and their caregivers. The person who inspires me from psychooncology domain is prof. Maggie Watson, also an IPOS active member.

    Interested in being profiled?

    Please email the following to [email protected] with the subject line “IPOS member profile submission”:

    1. Name
    2. Employment position
    3. Employer/Institution
    4. Country
    5. Twitter handle (if available)
    6. Jpg photo of yourself
    7. 50-to-200-word description that notes details on your practice, involvement with IPOS and something “fun or interesting” about yourself.


  • 19 Dec 2023 9:01 AM | John Chagnon (Administrator)
    The team at the IPOS would like to extend our best wishes to you all for a safe and peaceful holiday season. We hope you are able to enjoy the festivities with family and friends. Looking forward to what the new year will bring!

    Holiday Office Hours

    The IPOS Board of Directors and office will be unavailable from 5 p.m. ET on Friday, December 22, 2023 to Monday, January 1, 2024 inclusive. We will be back at 9 a.m. ET on January 2 and will make every effort to respond to all inquiries within the first 48 hours upon our return.
     
    See you all in the new year!


  • 15 Dec 2023 9:46 AM | John Chagnon (Administrator)


    I am Zeynep Kotan. I have been working as a psychiatrist since 2009. I worked as a psychiatrist in Ankara Abdurrahman Yurtaslan Oncology Training and Research Hospital between 2012-2019. We established a psychooncology department there where we introduced consultation liason service to Palliative Care, Medical Oncology, Hematology, Surgery and other medical departments. We conducted group therapies for breast cancer patients. I got my associate professor degree in 2007. I was assigned in the secretary and organization comittee of several psycooncology symposiums. I had a chance to work in Consultation Liason Deparment of Ankara University Psychiatry Unit where I had the opportunity to work with psychiatric issues related with diverse medical conditions including cancer. I have been working as a psychiatrist in my private office since 2020. I and my colleagues established Ankara Psychooncology Association in October 2022. We have done several educational activities towards professionals involved in oncology and towards cancer patients and their relatives. We have recently been involved psychooncology issues in disasters after the February 2023 earthquake disaster in Turkey. I am also a psychoanalytically oriented psychotherapist and interested in psychoanalytic issues in cancer patients. I am glad to be a part of IPOS. It is a big chance to have the opportunity to learn from colleagues interested in psychooncology from all around the world.

    Interested in being profiled?

    Please email the following to [email protected] with the subject line “IPOS member profile submission”:

    1. Name
    2. Employment position
    3. Employer/Institution
    4. Country
    5. Twitter handle (if available)
    6. Jpg photo of yourself
    7. 50-to-200-word description that notes details on your practice, involvement with IPOS and something “fun or interesting” about yourself.


  • 11 Dec 2023 10:46 AM | John Chagnon (Administrator)


    Irfan is a dedicated psycho-oncologist and a global health specialist, currently lending his expertise to Cancerless EU as an Advisor for Strategic Policy and Diplomatic Communication. With over a decade of experience in the field of psycho-oncology, he stands at the forefront of both practice and research. His work, recognized for its significance, has been featured in some of the world's most esteemed journals, including The Lancet.

    Irfan's career is driven by a profound commitment to improving the lives of cancer patients and their families, particularly in the context of global health. He believes that the intersection of psycho-oncology and global health policy can bring about meaningful change and greater awareness of the psychological aspects of the cancer journey. With a relentless passion for his work and a vision for a world where mental health is an integral part of cancer care, Irfan continues to make a remarkable impact on the field.  

    Interested in being profiled?

    Please email the following to [email protected] with the subject line “IPOS member profile submission”:

    1. Name
    2. Employment position
    3. Employer/Institution
    4. Country
    5. Twitter handle (if available)
    6. Jpg photo of yourself
    7. 50-to-200-word description that notes details on your practice, involvement with IPOS and something “fun or interesting” about yourself.


  • 7 Dec 2023 9:14 AM | John Chagnon (Administrator)

    Dear Healthcare Providers, Policy Makers, and Administrators:

    We are writing to invite you to participate in an important research study exploring the attitudes and beliefs towards Psychedelic-Assisted Therapies (PAT) among healthcare providers, policy makers, and people living with cancer.

    The study aims to examine current trends in attitudes towards PAT and how it might be integrated into existing treatments and research settings for psychosocial symptoms within cancer care in Canada.

    Participation in the study would involve completing an online survey, which should take approximately 20 minutes of your time. We are also inviting, those that are interested, to take part in a follow-up interview, which will provide an opportunity to discuss in more detail your experiences and attitudes towards PAT.

    All information collected during the study will be kept strictly confidential and no identifying information will be shared.

    Your participation in this study would contribute greatly to our understanding of how PAT might be integrated into cancer care settings and could ultimately benefit patients and healthcare providers in the future.

    Here are the essential resources for the study:

    The survey link for participation: https://redcap.link/PATCANSURVEY

    Our dedicated study website for further information: https://www.psychedelictherapiesforcancer.com/

    If you have any questions or concerns, please do not hesitate to contact the study coordinator, Haley Mather at:

    P: 403-923-1964
    E: [email protected]

    Thank you for considering our request.

    Sincerely,

    Haley Mather

    Principal Investigator: Dr. Linda Ellen Carlson

    Please note the above was submitted to the IPOS Research Committee via the "RESEARCH STUDY PEER REVIEW" process. For more information, please go to https://ipos-society.org/Peer-Review

International Psycho-Oncology Society
1 - 189 Queen Street East
Toronto, ON M5A 1S2

244 Fifth Avenue, Suite L296
New York, NY 10001

T: +1 416-968-0260
[email protected]



Follow IPOS

© 2024 International Psycho-Oncology Society 

 Website powered by Funnel Communications Inc.